Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells

Journal of the National Cancer Institute

Volumn 89, Issue 17, 1997, Pages 1271-1276

  Hu, Guiying ^a   Liu, Wenbiao ^a   Mendelsohn, John ^a   Ellis, Lee M ^a   Radinsky, Robert ^a   Andreeff, Michael ^a   Deisseroth, Albert B ^a,b,c  

^a UNIVERSITY OF TEXAS   (United States)

^b YALE CANCER CENTER   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ANTIBODY SPECIFICITY; ARTICLE; CARCINOMA CELL; CELL IMMORTALIZATION; CELL PROLIFERATION; DNA SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PAPILLOMA VIRUS; PROTEIN PROCESSING; SEQUENCE HOMOLOGY; TUMOR GROWTH; UTERINE CERVIX CARCINOMA; VIRUS EXPRESSION;

EID: 0030817148     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.17.1271     Document Type: Article

References (43)

1. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 1987;,56:881-914.
2. Libermann TA, Razon N, Bartal AD, Yarden T, Schlessinger J, Soreq H. Expression of epidermal growth factor receptors in human brain tumors. Cancer Res 1984;44:753-60.
3. Ozanne B, Richards CS, Hendler F, Burns D, Gusterson B. Over-expression of the EGF receptor is a hallmark of squarmous cell carcinomas. J Pathol 1986;149:9-14.
4. Sobol RE, Astarita RW, Hofeditz C, Masui H, Fairshter R, Royston I, et al. Epidermal growth factor receptor expression in human lung carcinomas defined by a monoclonal antibody. J Natl Cancer Inst 1987;79:403-7.
5. Neal DE, Marsh C, Bennet MK, Abel PD, Hall RR, Sainshury JR, et al. Epidermal growth factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet 1985;1:366-8.
6. Harris AL, Nicholson S, Sainsbury JR, Farndon J, Wright C. Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions with neu. J Steroid Biochem 1989;34:123-31.
7. Sainsbury JR, Malcolm AJ, Appleton DR, Farndon JR, Harris AL. Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol 1985;38:1225-8.
8. Veale D, Ashcroft T. Marsh C, Gibson GJ, Harris AL. Epidermal growth factor receptors in non-small cell lung cancer. Br J Cancer 1987;55:513-6.
9. Veale D, Kerr N, Gibson GJ, Harris AL. Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer. Cancer Res 1989;49:1313-7.
10. Mendelsohn J. The epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies. Senim Cancer Biol 1990;1: 334-44.
11. Kohler M. Janz I. Wintzer HO. Wagner E. Bauknecht T. The expression of EGF receptors. EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance. Anticancer Res 1989;9: 1537-47.
12. Bauknecht T, Kohler M. Janz I, Pfleiderer A. The occurrence of epidermal growth factor receptors and the characterization of EGF-like factors in human ovarian. endometrial, cervical and breast cancer. EGF receptors and factors in gynecological carcinomas. J Cancer Res Clin Oncol 1989;115: 193-9.
13. Suzuki M, Furugen Y, Miyazaki R, Yamamoto T. Takada M. Sequential changes of HPV DNA, the expression of EGF-R and CD-14. and histopathological findings in HPV infected benign epithelium and dysplastic lesions of the uterine cervix. Nippon Sanka Fujinka Gakkai Zasshi. 1992; 44:805-12.
14. Sizemore N, Rorke EA. Human papillomavirus 16 immortalization of normal human ectocervical epithelial cells alters retinoic acid regulation of cell growth and epidermal growth factor receptor expression. Cancer Res 1993; 53:4511-7.
15. Maruo T, Yamasaki M, Ladines-Llave CA, Mochizuki M. Immunohistochemical demonstration of elevated expression of epidermal growth factor receptor in the neoplastic changes of cervical squamous epithelium. Cancer 1992;69:1182-7.
16. Zur Hausen H. Papillomaviruses in human cancers. Mol Carcinogen 1988; 1:147-50.
17. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, Zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 1984;3:1151-7.
18. Durst M, Gissmann L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A 1983;80:3812-5.
19. Lorincz AT, Lancaster WD, Temple GF. Cloning and characterization of the DNA of a new human papillomavirus from a woman with dysplasia of the uterine cervix. J Virol 1986;58:225-9.
20. Agarwal C, Rorke EA, Irwin JC, Eckert RL. Immortalization by human papillomavirus type 16 alters retinoid regulation of human ectocervical epithelial cell differentiation. Cancer Res 1991;51:3982-9.
21. Pirisi L, Batova A, Jenkins GR, Hodam JR, Creek KE. Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoids. Cancer Res 1992;52:187-93.
22. Cripe TP, Haugen TH, Turk JP, Tabatabai TF, Schmid PG 3d, Durst M, et al. Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 transactivator and represser gene products: implications for cervical carcinogenesis. EMBO J 1987;6:3745-53.
23. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985;314:111-4.
24. Schneider-Gadicke A, Schwarz E. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J 1986;5:2285-92.
25. Shirasawa H, Tomita Y, Sekiya S, Takamizawa H, Simizu B. Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas. J Gen Virol 1987;68 (Pt 2):583-91.
26. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 1987;61:962-71.
27. Dyson N, Howley PM, Munger K, Harlow E. The human papillomavirus-16 E7 oncoprotein is able to bind the retinoblastoma gene product. Science 1989;243:934-7.
28. Werness BA. Levine AJ. Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990;248:76-9.
29. Hawley-Nelson P. Vousden KH. Hubbert NL. Lowy DR. Schiller JT. HPV 16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 1489;8:3905-10.
30. Romney SL. Palan PR. Duttagupta C. Wasscrtheil-Smoller S. Wylie J. Miller G. et al. Retinoids and the prevention of cervical dysplasias. Am J Obstet Gynecol 1981;141:890-4.
31. Meyskens FL Jr. Graham V. Chvapil M. Dorr RT. Alberts DS. Surwit EA. A phase I trial of β-all-trans-retinoic acid delivered via collagen sponge and a cervical cap for mild or moderato intraepithelial cervical neoplasia. J Natl Cancer Inst 1983;71:921-5.
32. Meyskens FL Jr. Surwit ES. Clinical experience with topical tretinoin in the treatment of cervical dysplasia. J Am Acad Dermatol 1986:15(4 Pt 2): 826-9.
33. Weiner SA. Surwit EA. Graham VE. Meyskens FL Jr. A phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacy. Invest New Drugs 1986;4:241-4.
34. Graham V. Surwit ES. Weiner S. Meyskens FL Jr. Phase II trial of β-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via collagen sponge and cervical cap. West J Med 1986;145:192-5.
35. Bartsch D. Boye B. Baust C. zur Hausen H. Schwarz E. Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor β gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J 1992;11:2283-91.
36. Hu G, Liu W, Hanania EG, Fu S, Wang T, Deisseroth A. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papillomavirus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Cancer Gene Ther 1995;2:19-32.
37. Ellis LM, Liu W, Wilson M. Down-regulation of vascular endothelial growth factor in human colon carcinoma cell lines by antisense transfection decreases endothelial cell proliferation. Surgery 1996;102:871-8.
38. Radinsky R, Kraemer PM, Raines MA, Kunf HJ, Culp LA. Amplification and rearrangement of the Kirsten ras oncogene in virus-transformed BALB/c 3T3 cells during malignant tumor progression. Proc Natl Acad Sci U S A 1987;84:5143-7.
39. Sugawa H, Beniko M, lmura H, Mori T. Characterization of epidermal growth factor receptor in a rat thyroid cell line, FRTL-5. Biochem Biophys Res Commun 1993;1:390-7.
40. Ishikawa J, Maeda S, Sugiyama T, Nishimura R, Mizoguchi A, Kamidono S. EGF stimulates anchorage-independent growth of a human bladder carcinoma cell line (KU1) with an amplified and over-expressed EGF receptor gene. Int J Cancer 1989;44:1000-4.
41. Donato NJ, Yan DH, Hung MC, Rosenblum MG. Epidermal growth factor receptor expression and function control cytotoxic responsiveness to tumor necrosis factor in ME-180 squamous carcinoma cells. Cell Growth Differ 1993;4:411-9.
42. Fan Z, Masui H, Atlas I, Mendelsohn J. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res 1993;53:4322-8.
43. Fan Z, Lu Y, Wu X, Mendelsohn J. Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells. J Biol Chem 1994;269:27595-602.